Title
Category
Credits
Event date
Cost
  • Antidepressants
  • Anxiety
  • Depression
  • Diagnostic Tools
  • Substance Use Disorders
  • Suicide
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Identification of depression is crucial, as untreated depression is linked to functional impairment and suicide. Learn from an expert about how measurement-based care provides a way to improve the recognition of depression and comorbid conditions.
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Diagnostic Tools
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What are the steps for diagnosing Alzheimer disease? Are you familiar with diagnostic criteria and assessment tools? In this webcast, walk through the process with an expert.
  • Alzheimer Disease
  • Dementia
  • Neurology
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Disclosing a diagnosis of dementia can be one of the most challenging aspects of care for clinicians. Here, learn strategies for disclosing the diagnosis.
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Diagnostic Tools
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Evaluating cognition in older adults when possible cognitive impairment and dementia are present can be quite beneficial. Learn more in this CME activity.
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Primary Care
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Learn from experts in neurology, psychiatry, neuropsychology, and primary care about working with patients and care partners to create management plans for Alzheimer’s disease that ensure safety, optimize patient autonomy, and minimize agitation and conflict.
  • Alzheimer Disease
  • Cognition
  • Delivery of Care
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Patient/Physician Communication
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
In a series of brief video segments, experts in neurology, psychiatry, and primary care discuss the diagnosis and treatment of Alzheimer’s disease.
  • Antipsychotics
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Finally, you can offer patients with tardive dyskinesia approved medications that reduce symptoms. In this CME, Dr Leslie Citrome reviews the evidence.
  • Antipsychotics
  • Bipolar Disorder
  • Depression
  • Diagnostic Tools
  • Schizophrenia/ Schizoaffective Disorders
  • Tardive Dyskinesia
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Tardive dyskinesia must be detected early to minimize the risk of permanence. Dr Stephen Saklad provides a refresher in this brief CME activity.
  • Adherence
  • Antipsychotics
  • Delivery of Care
  • Psychotic Disorders
  • Schizophrenia/ Schizoaffective Disorders
  • Side Effects
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What are some of the challenges you face in overcoming adherence issues and providing patient-centered care for people living with schizophrenia? Drs Harvey and Kane offer evidence and clinical experience on these topics in this journal CME activity.
  • Attention-Deficit/Hyperactivity Disorder
  • Substance Use Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
How does comorbid attention-deficit/hyperactivity disorder (ADHD) affect individuals with substance use disorder (SUD)? Is treatment for ADHD associated with retention in outpatient SUD therapy?

Pages